HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kinga I Gawlik Selected Research

Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)

10/2017Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.
4/2011Transgenic expression of Laminin α1 chain does not prevent muscle disease in the mdx mouse model for Duchenne muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kinga I Gawlik Research Topics

Disease

13Muscular Dystrophies (Muscular Dystrophy)
01/2020 - 03/2006
2Inflammation (Inflammations)
10/2019 - 10/2017
2Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 09/2006
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2017 - 04/2011
2Fibrosis (Cirrhosis)
12/2011 - 07/2010
1Paralysis (Palsy)
01/2019
1Disease Progression
08/2018
1Muscular Diseases (Myopathy)
11/2014
1Muscle Weakness
11/2014
1Atrophy
12/2011

Drug/Important Bio-Agent (IBA)

13Laminin (Merosin)IBA
01/2020 - 03/2006
2Dystroglycans (Dystroglycan)IBA
06/2007 - 03/2006
2laminin AIBA
09/2006 - 03/2006
1Extracellular Matrix ProteinsIBA
10/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Biomarkers (Surrogate Marker)IBA
08/2018
1MicroRNAs (MicroRNA)IBA
08/2018
1OsteopontinIBA
10/2017
1Galectin 3 (LGALS3)IBA
10/2017
13-methyladenineIBA
12/2011
1Creatine Kinase (Creatine Phosphokinase)IBA
07/2010
1GlycosyltransferasesIBA
06/2007
1integrin alpha7beta1IBA
03/2006
1IntegrinsIBA
03/2006

Therapy/Procedure

1Therapeutics
10/2017